Drug Shortage Report for FLOMAX CR
Report ID | 210443 |
Drug Identification Number | 02270102 |
Brand name | FLOMAX CR |
Common or Proper name | FLOMAX CR |
Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | TAMSULOSIN HYDROCHLORIDE |
Strength(s) | 0.4MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 3X10 |
ATC code | G04CA |
ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2023-11-24 |
Actual start date | |
Estimated end date | 2024-02-05 |
Actual end date | 2024-01-23 |
Shortage status | Resolved |
Updated date | 2024-01-24 |
Company comments | Demand increase due to stock out multiple generics |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2024-01-24 | English | Compare |
v9 | 2024-01-23 | French | Compare |
v8 | 2024-01-23 | English | Compare |
v7 | 2024-01-23 | English | Compare |
v6 | 2023-11-25 | English | Compare |
v5 | 2023-11-21 | French | Compare |
v4 | 2023-11-21 | English | Compare |
v3 | 2023-11-21 | English | Compare |
v2 | 2023-11-16 | French | Compare |
v1 | 2023-11-16 | English | Compare |
Showing 1 to 10 of 10